
The first commercial application of the Visby Medical single-use, rapid PCR platform received FDA EUA in 2020 for COVID-19 testing. Currently under review with the FDA is a multiplex assay for Chlamydia, Gonorrhea, and Trichomonas from a single sample, at the point of care.
Resources
Videos
Related Listings
PixCell Medical

Simplify real-time blood testing, for everyone, everywhere. We help health practitioners and patients get rapid…
Lumos Diagnostics

Innovation at the point-of-care Lumos Diagnostics specializes in rapid, cost-effective and complete point-of-care diagnostic test…